United States: US FDA Advisory Committee Backs Gene Therapy For Rare Form Of Blindness – Mondaq News Alerts
|
United States: US FDA Advisory Committee Backs Gene Therapy For Rare Form Of Blindness
Mondaq News Alerts On October 12, 2017, the U.S. Food and Drug Administration's (FDA) Cellular, Tissue and Gene Therapies Advisory Committee has paved the way for the agency's first approval of a gene therapy to treat a disease caused by a genetic mutation. A panel of … |
